Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 12, 2014
March 06 2014 - 11:51AM
Business Wire
Transgenomic, Inc. (OTC/BB: TBIO) today announced the
following Webcast:
What: Transgenomic, Inc. Fourth Quarter 2013
Financial Results and Business Update Conference Call When:
Wednesday, March 12, 2014 @ 5:00 p.m. Eastern Where:
http://www.videonewswire.com/event.asp?id=98380
How: Live over the Internet -- Simply log on to the web at
the address above. Contact: Investor Relations, 402-452-5416
To access the call via telephone, dial 866-952-1906 from the
U.S. and Canada or 785-424-1825 for international participants and
enter conference ID TRANS. A telephone replay will be available
from 8:00 p.m. Eastern Time on March 12, 2014 through 11:59 p.m.
Eastern Time on March 26, 2014 by dialing 800-677-7085 (domestic)
or 402-220-0665 (international).
About Transgenomic, Inc.
Transgenomic, Inc. (www.transgenomic.com) is a global
biotechnology company advancing personalized medicine in
cardiology, oncology, and inherited diseases. The Company has three
complementary business units: Patient Testing, Biomarker
Identification, and Genetic Assays and Platforms, which provide
specialized diagnostic tests, contract research services for drug
development, and equipment, reagents and other consumables for
clinical and research applications in molecular testing and
cytogenetics.
Investor ContactArgot PartnersDavid Pitts,
212-600-1902david@argotpartners.comorCompany
ContactTransgenomic, Inc.Donna Christian,
402-452-5416investorrelations@transgenomic.com
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Sep 2023 to Sep 2024